FN1 and cancer: Therefore, through their direct interaction with the receptor, they are able to inhibit cell adhesion to integrin endogenous ligands and to prevent FN-induced activation of intracellular signaling pathways, thus blocking α4β1 integrin functions that are involved in the pathogenesis of several diseases, including different types of cancer and inflammatory diseases.